Copyright Reports & Markets. All rights reserved.

Global Pharma Ophthalmic Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Pharma Ophthalmic Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pharma Ophthalmic Market Size Growth Rate by Product
      • 1.4.2 Retinal Disorders Drugs
      • 1.4.3 Allergic, Inflammatory and Infective Drugs
      • 1.4.4 Glaucoma Drugs
      • 1.4.5 Dry Eye Drugs
      • 1.4.6 Other Ophthalmic Drugs
    • 1.5 Market by End User
      • 1.5.1 Global Pharma Ophthalmic Market Size Growth Rate by End User
      • 1.5.2 Glaucoma
      • 1.5.3 Dry Eye Syndrome
      • 1.5.4 Retinal Diseases
      • 1.5.5 Other Ophthalmic Indications
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pharma Ophthalmic Market Size
      • 2.1.1 Global Pharma Ophthalmic Revenue 2014-2025
      • 2.1.2 Global Pharma Ophthalmic Sales 2014-2025
    • 2.2 Pharma Ophthalmic Growth Rate by Regions
      • 2.2.1 Global Pharma Ophthalmic Sales by Regions
      • 2.2.2 Global Pharma Ophthalmic Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pharma Ophthalmic Sales by Manufacturers
      • 3.1.1 Pharma Ophthalmic Sales by Manufacturers
      • 3.1.2 Pharma Ophthalmic Sales Market Share by Manufacturers
      • 3.1.3 Global Pharma Ophthalmic Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pharma Ophthalmic Revenue by Manufacturers
      • 3.2.1 Pharma Ophthalmic Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pharma Ophthalmic Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pharma Ophthalmic Price by Manufacturers
    • 3.4 Pharma Ophthalmic Manufacturing Base Distribution, Product Types
      • 3.4.1 Pharma Ophthalmic Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pharma Ophthalmic Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pharma Ophthalmic Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pharma Ophthalmic Sales by Product
    • 4.2 Global Pharma Ophthalmic Revenue by Product
    • 4.3 Pharma Ophthalmic Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pharma Ophthalmic Breakdown Data by End User

    6 North America

    • 6.1 North America Pharma Ophthalmic by Countries
      • 6.1.1 North America Pharma Ophthalmic Sales by Countries
      • 6.1.2 North America Pharma Ophthalmic Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pharma Ophthalmic by Product
    • 6.3 North America Pharma Ophthalmic by End User

    7 Europe

    • 7.1 Europe Pharma Ophthalmic by Countries
      • 7.1.1 Europe Pharma Ophthalmic Sales by Countries
      • 7.1.2 Europe Pharma Ophthalmic Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pharma Ophthalmic by Product
    • 7.3 Europe Pharma Ophthalmic by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pharma Ophthalmic by Countries
      • 8.1.1 Asia Pacific Pharma Ophthalmic Sales by Countries
      • 8.1.2 Asia Pacific Pharma Ophthalmic Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pharma Ophthalmic by Product
    • 8.3 Asia Pacific Pharma Ophthalmic by End User

    9 Central & South America

    • 9.1 Central & South America Pharma Ophthalmic by Countries
      • 9.1.1 Central & South America Pharma Ophthalmic Sales by Countries
      • 9.1.2 Central & South America Pharma Ophthalmic Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pharma Ophthalmic by Product
    • 9.3 Central & South America Pharma Ophthalmic by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pharma Ophthalmic by Countries
      • 10.1.1 Middle East and Africa Pharma Ophthalmic Sales by Countries
      • 10.1.2 Middle East and Africa Pharma Ophthalmic Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pharma Ophthalmic by Product
    • 10.3 Middle East and Africa Pharma Ophthalmic by End User

    11 Company Profiles

    • 11.1 Novartis
      • 11.1.1 Novartis Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis Pharma Ophthalmic Products Offered
      • 11.1.5 Novartis Recent Development
    • 11.2 Allergan
      • 11.2.1 Allergan Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Allergan Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Allergan Pharma Ophthalmic Products Offered
      • 11.2.5 Allergan Recent Development
    • 11.3 Roche
      • 11.3.1 Roche Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Roche Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Roche Pharma Ophthalmic Products Offered
      • 11.3.5 Roche Recent Development
    • 11.4 Valeant
      • 11.4.1 Valeant Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Valeant Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Valeant Pharma Ophthalmic Products Offered
      • 11.4.5 Valeant Recent Development
    • 11.5 Regeneron
      • 11.5.1 Regeneron Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Regeneron Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Regeneron Pharma Ophthalmic Products Offered
      • 11.5.5 Regeneron Recent Development
    • 11.6 Santen
      • 11.6.1 Santen Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Santen Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Santen Pharma Ophthalmic Products Offered
      • 11.6.5 Santen Recent Development
    • 11.7 Bayer
      • 11.7.1 Bayer Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bayer Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bayer Pharma Ophthalmic Products Offered
      • 11.7.5 Bayer Recent Development
    • 11.8 Pfizer
      • 11.8.1 Pfizer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Pharma Ophthalmic Products Offered
      • 11.8.5 Pfizer Recent Development
    • 11.9 Senju
      • 11.9.1 Senju Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Senju Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Senju Pharma Ophthalmic Products Offered
      • 11.9.5 Senju Recent Development
    • 11.10 Akorn
      • 11.10.1 Akorn Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Akorn Pharma Ophthalmic Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Akorn Pharma Ophthalmic Products Offered
      • 11.10.5 Akorn Recent Development

    12 Future Forecast

    • 12.1 Pharma Ophthalmic Market Forecast by Regions
      • 12.1.1 Global Pharma Ophthalmic Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pharma Ophthalmic Revenue Forecast by Regions 2019-2025
    • 12.2 Pharma Ophthalmic Market Forecast by Product
      • 12.2.1 Global Pharma Ophthalmic Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pharma Ophthalmic Revenue Forecast by Product 2019-2025
    • 12.3 Pharma Ophthalmic Market Forecast by End User
    • 12.4 North America Pharma Ophthalmic Forecast
    • 12.5 Europe Pharma Ophthalmic Forecast
    • 12.6 Asia Pacific Pharma Ophthalmic Forecast
    • 12.7 Central & South America Pharma Ophthalmic Forecast
    • 12.8 Middle East and Africa Pharma Ophthalmic Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pharma Ophthalmic Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Pharma Ophthalmic market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pharma Ophthalmic market based on company, product type, end user and key regions.

      This report studies the global market size of Pharma Ophthalmic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pharma Ophthalmic in these regions.
      This research report categorizes the global Pharma Ophthalmic market by top players/brands, region, type and end user. This report also studies the global Pharma Ophthalmic market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novartis
      Allergan
      Roche
      Valeant
      Regeneron
      Santen
      Bayer
      Pfizer
      Senju
      Akorn

      Market size by Product
      Retinal Disorders Drugs
      Allergic, Inflammatory and Infective Drugs
      Glaucoma Drugs
      Dry Eye Drugs
      Other Ophthalmic Drugs
      Market size by End User
      Glaucoma
      Dry Eye Syndrome
      Retinal Diseases
      Other Ophthalmic Indications

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Pharma Ophthalmic market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Pharma Ophthalmic market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Pharma Ophthalmic companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Pharma Ophthalmic submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Pharma Ophthalmic are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pharma Ophthalmic market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now